CL
CARNEY LLOYD Director
Board M
US US · SEC (Form 4)
Discover the complete record of transactions filed by CARNEY LLOYD, Director. Director active across 4 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 18 filings have been published. Total volume traded: €4.3m. The latest transaction was disclosed on 1 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 18 total
01,449 shares 0
Common Stock
SEC:0000899243-22-016332:0 · 1 May 2022
4,519 shares
Common Stock
SEC:0000899243-22-009420:0 · 4 Mar 2022
01,114 shares 0
Class A Common Stock
SEC:0001127602-22-002333 · 25 Jan 2022
01,114 shares 0
Class A Common Stock
SEC:0001127602-22-002333:0 · 25 Jan 2022
€277,385 5,670 shares @ €48.9215 14.5% of flow
Common Stock
SEC:0001002517-22-000012 · 4 Jan 2022
€277,385 5,670 shares @ €48.9215 7.3% of flow
Common Stock
SEC:0001002517-22-000012:0 · 4 Jan 2022
€4 4,519 shares @ €0.0009 0.0% of flow
Common Stock
SEC:0001002517-22-000007 · 1 Jan 2022
€4 4,519 shares @ €0.0009 0.0% of flow
Common Stock
SEC:0001002517-22-000007:0 · 1 Jan 2022
02,597 shares 0
Common Stock
SEC:0001209191-21-070920 · 20 Dec 2021
02,597 shares 0
Common Stock
SEC:0001209191-21-070920:0 · 20 Dec 2021
€4,678 100 shares @ €46.7811 0.2% of flow
Common Stock
SEC:0001002517-21-000048 · 14 Sept 2021
€4,678 100 shares @ €46.7811 0.1% of flow
Common Stock
SEC:0001002517-21-000048:0 · 14 Sept 2021
€2m 36,002 shares @ €45.1624 42.6% of flow
Common Stock
SEC:0001002517-21-000037:0 · 8 Jun 2021
€2m 36,002 shares @ €45.1624 85.2% of flow
Common Stock
SEC:0001002517-21-000037 · 8 Jun 2021
€241,802 1,300 shares @ €186.0019 100.0% of flow
Class A Common Stock
SEC:0001127602-21-017205 · 17 May 2021
€241,802 1,300 shares @ €186.0019 0.0000% mcap 50.0% of flow
Class A Common Stock
SEC:0001127602-21-017205:0 · 17 May 2021
01,842 shares 0
Common Stock
SEC:0001209191-21-029842 · 1 May 2021
01,842 shares 0
Common Stock
SEC:0001209191-21-029842:0 · 1 May 2021
About CARNEY LLOYD Lloyd Carney is an executive at Vertex Pharmaceuticals Inc, a biotechnology company based in Massachusetts.